Stocks gain ground and put S&P 500 and Nasdaq on a path for all-time highs
Stocks rose and put Wall Street on track to finish the strong week at an all-time high. The S&P 500 rose 0.3% Friday and is on track to surpass its …
American Tower REIT stock outperforms competitors despite losses on the day
Shares of American Tower REIT AMT slid 1.23% to $217.52 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.80% to 6,141.02 …
Canadian Pacific Kansas City Ltd. stock rises Thursday, outperforms market
Shares of Canadian Pacific Kansas City Ltd. CP inched 0.79% higher to C$107.77 Thursday, in what proved to be an all-around positive trading session for the Canadian market, with the S&P/TSX Composite …
What’s Going On With Tilray Brands Stock Today?
According to Benzinga Pro, TLRY stock has lost over 76% in the past year. In a separate release, Montauk Brewing Co., a Tilray Brands company, announced a limited-edition collaboration with lifestyle …
Kinross Gold Corp. stock rises Wednesday, outperforms market
Shares of Kinross Gold Corp. K inched 0.19% higher to C$21.02 Wednesday, in what proved to be an otherwise all-around poor trading session for the Canadian market, with the S&P/TSX Composite Index …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
2 Stocks Down More Than 90% That Still Aren’t Worth Buying
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don’t miss out on the latest top 10 list, available when you …
Neural Therapeutics Acquires Stake in German CBD Retailer Hanf.com
An announcement from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics Inc. has completed the acquisition of a 30.75% …
CenTex CBD is closing their doors amidst uncertainty and political debate
The ongoing battle to ban THC in Texas led to their decision.
Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure
CardiolRx did not have a significant impact on left ventricular extracellular volume (LV-ECV) in the Phase II ARCHER study.
InnoCan Pharma Leads 3 Noteworthy TSX Penny Stocks
As we head into the second half of 2025, trade negotiations and tariff discussions between major economies like the U.S. and China are creating a complex backdrop for investors to navigate. Despite …
Federal Crackdown On Hemp-Derived THC, Cannabinoids Advances In Congress, Industry Warns Of Collapse
House GOP bill redefines hemp to ban most THC products. Industry warns of economic collapse if THCA, delta-8 and CBD are outlawed.
TRUBAR Inc.
TRUBAR Inc. advanced stock charts by Barron’s. View TRBR historical stock data and compare to other stocks, and exchanges.
3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies
The obesity market has garnered much interest lately, propelled by the success of GLP-1 therapies Wegovy and Zepbound, marketed by pharma giants Novo Nordisk NVO and Eli Lilly LLY, respectively. This …
CBD Offices Face Prolonged Challenges
The sector is in the early innings of a prolonged realignment and development is likely to remain depressed.
Recent Comments